NCT07015788

Brief Summary

This study aims to evaluate the effect of different peach varieties on the glycemic index (GI) in healthy adult participants. While peaches are generally classified as low-GI fruits, variations in sugar composition, fiber content, and ripeness among different cultivars may influence their glycemic response. By assessing and comparing the GI values of several commonly consumed peach varieties, this trial seeks to provide more precise dietary recommendations for glycemic control and support better fruit selection for individuals managing blood glucose levels.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 11, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

June 3, 2025

Last Update Submit

June 3, 2025

Conditions

Keywords

glycemic indexglycemic load

Outcome Measures

Primary Outcomes (1)

  • Glycemic Index

    Participants will consume a standardized portion of a peach variety containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

    2 hours post-consumption (per intervention)

Secondary Outcomes (2)

  • Incremental Area Under the Curve (iAUC) for Blood Glucose

    0-120 minutes post-consumption

  • Peak Blood Glucose Concentration

    0-120 minutes post-consumption

Study Arms (1)

Single group (cross over)

ACTIVE COMPARATOR

Participants will consume 50 grams of glucose solution. This serves as the reference standard for calculating glycemic index values of the peach varieties.

Other: EARLY GRANDOther: SPRING CREST PEACHOther: INDIAN BLOOD

Interventions

Participants will consume a standardized portion of peach variety A containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Single group (cross over)

Participants will consume a standardized portion of peach variety B containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Single group (cross over)

Participants will consume a standardized portion of peach variety C containing 50 grams of available carbohydrates. Capillary blood glucose levels will be measured at multiple time points post-consumption to assess glycemic response.

Single group (cross over)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI between 18.5-24.9 kg/m²
  • Normal fasting blood glucose (\<100 mg/dL)

You may not qualify if:

  • Use of medications or supplements that affect glucose levels
  • Allergy to peaches or intolerance to test/reference foods
  • Pregnant or breastfeeding women
  • Smoking or use of recreational drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehman Medical Institue

Peshawar, Khyber Pakhtunkhwa, 092, Pakistan

Location

Related Publications (2)

  • Basit et al. (2022). J Pak Med Assoc. (Health burden).

    BACKGROUND
  • IDF Diabetes Atlas 2021 (Pakistan ranked 3rd in diabetes cases).

    BACKGROUND

MeSH Terms

Interventions

CD44 protein, human

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate proffesor

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

June 1, 2025

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

June 11, 2025

Record last verified: 2025-05

Locations